Exploring S. Typhi-Specific HLA-E Restricted Immune Responses in Pediatric and Adult Ty21a Recipients

Similar documents
Immune response and correlates of protection against typhoid

Recent advances on the complex and multifaceted T memory and effector immunity elicited to S. Typhi in humans

x Lymphocyte count /µl CD8+ count/µl 800 Calculated

Naive, memory and regulatory T lymphocytes populations analysis

ORIGINAL RESEARCH. Systemic and Terminal Ileum Mucosal Immunity Elicited by Oral Immunization With the Ty21a Typhoid Vaccine in Humans

Cellular Immune response. Jianzhong Chen, Ph.D Institute of immunology, ZJU

Cytotoxicity assays. Rory D. de Vries, PhD 1. Viroscience lab, Erasmus MC, Rotterdam, the Netherlands

Live oral vaccine approaches to typhoid and paratyphoid vaccines

NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections

IMMUNOLOGICAL MEMORY. CD4 T Follicular Helper Cells. Memory CD8 T Cell Differentiation

Alessandra Franco MD PhD UCSD School of Medicine Department of Pediatrics Division of Allergy Immunology and Rheumatology

TCR, MHC and coreceptors

Third line of Defense

staining and flow cytometry

Multi-Virus-Specific T cell Therapy for Patients after HSC and CB Transplant

New technologies for studying human immunity. Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine

The Adaptive Immune Responses

Estimating primate effector T cell responses to DNA vaccination

Innate and Cellular Immunology Control of Infection by Cell-mediated Immunity

Supplemental materials

HLA-E restricted responses in Tuberculosis

Rapid perforin upregulation directly ex vivo by CD8 + T cells is a defining characteristic of HIV elite controllers

Gp96-Ig-SIV VACCINES INDUCE PREDOMINANT IMMUNE RESPONSES AT MUCOSAL SITES

6/7/17. Immune cells. Co-evolution of innate and adaptive immunity. Importance of NK cells. Cells of innate(?) immune response

Third line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!

The role of CMV in the long term outcome for older Australians, renal transplant recipients and HIV patients

Micro 204. Cytotoxic T Lymphocytes (CTL) Lewis Lanier

7/14/2014. Multiple immune effector mechanisms contribute to protection influenza. What is a correlate of protection?

Supplementary Fig. 1: Ex vivo tetramer enrichment with anti-c-myc beads

Structure and Function of Antigen Recognition Molecules

IMMUNOTHERAPY FOR CANCER A NEW HORIZON. Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust

Supplementary Figure 1

1. Overview of Adaptive Immunity

Potential cross reactions between HIV 1 specific T cells and the microbiome. Andrew McMichael Suzanne Campion

EBV Infection and Immunity. Andrew Hislop Institute for Cancer Studies University of Birmingham

Memory loss: T cell subsets associated with mortality in HIV+ and HIV veterans

CONTRACTING ORGANIZATION: Johns Hopkins University School of Medicine Baltimore, MD 21205

Immunology Basics Relevant to Cancer Immunotherapy: T Cell Activation, Costimulation, and Effector T Cells

Long-term persistence of T cell memory in Italian vaccinees

T Cell Activation. Patricia Fitzgerald-Bocarsly March 18, 2009

Cellular Immunity in Aging and HIV: Correlates of Protection. Immune Senescence

Cell Mediated Immunity CELL MEDIATED IMMUNITY. Basic Elements of Cell Mediated Immunity (CMI) Antibody-dependent cell-mediated cytotoxicity (ADCC)

How T cells recognize antigen: The T Cell Receptor (TCR) Identifying the TCR: Why was it so hard to do? Monoclonal antibody approach

A second type of TCR TCR: An αβ heterodimer

Practical Solution: presentation to cytotoxic T cells. How dendritic cells present antigen. How dendritic cells present antigen

Madhav V. Dhodapkar, Joseph Krasovsky, Ralph M. Steinman, and Nina Bhardwaj

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Antigen Presentation to T lymphocytes

Fluorochrome Panel 1 Panel 2 Panel 3 Panel 4 Panel 5 CTLA-4 CTLA-4 CD15 CD3 FITC. Bio) PD-1 (MIH4, BD) ICOS (C398.4A, Biolegend) PD-L1 (MIH1, BD)

Cell-mediated Immunity

What to Measure, How to Measure It

Immunity and Cancer. Doriana Fruci. Lab di Immuno-Oncologia

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Evidence review on the immunogenicity, efficacy/effectiveness and safety of typhoid conjugate vaccines

Immunology. T-Lymphocytes. 16. Oktober 2014, Ruhr-Universität Bochum Karin Peters,

Adaptive Immune System

Immune Tolerance. Kyeong Cheon Jung. Department of Pathology Seoul National University College of Medicine

Advances in Cancer Immunotherapy

the HLA complex Hanna Mustaniemi,

Immune response. This overview figure summarizes simply how our body responds to foreign molecules that enter to it.

Vaccine Delivery and TLR Ligands Influence the Quality of T cell Responses in NHP. Robert A. Seder, M.D. Vaccine Research Center NIAID, NIH

Biology of Immune Aging

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

Off-Label Treatments. Clinical Trials for Recurrent GBM UCSF Radiation Oncology Course: Management of Recurrent Disease. Outline

Commercially available HLA Class II tetramers (Beckman Coulter) conjugated to

Immunology 2011 Lecture 14 Cell Interactions in CMI II 7 October

New insights into CD8+ T cell function and regulation. Pam Ohashi Princess Margaret Cancer Centre

THE EFFECT OF CD48 INHIBITION IN MOUSE MEMORY T CELLS AND CELIAC DISEASE. Suzannah Bergstein

C. Incorrect! MHC class I molecules are not involved in the process of bridging in ADCC.

supplemental Figure 1

Supporting Information

ASSESSING THE FUNCTION OF EBV-SPECIFIC CD4 + T cells

General Overview of Immunology. Kimberly S. Schluns, Ph.D. Associate Professor Department of Immunology UT MD Anderson Cancer Center

The Major Histocompatibility Complex (MHC)

Solution key Problem Set

The Immune Epitope Database Analysis Resource: MHC class I peptide binding predictions. Edita Karosiene, Ph.D.

New evidences. Biomarkers to explore immunoparalysis: what future for immunostimulation? B. François CHU Limoges (France)

Immune correlates of protection from congenital cytomegalovirus after primary infection in pregnancy

Treatment with IL-7 Prevents the Decline of Circulating CD4 + T Cells during the Acute Phase of SIV Infection in Rhesus Macaques

M.Sc. III Semester Biotechnology End Semester Examination, 2013 Model Answer LBTM: 302 Advanced Immunology

Vaxchora. (cholera vaccine, live attenuated) New Product Slideshow

Manuscript: OX40 signaling is involved in the autoactivation of CD4 + CD28 - T cells and contributes to pathogenesis of autoimmune arthritis

Advances in Adoptive Cellular Therapy of Cancer. Melanoma Bridge Meeting December 5, 2014

Basic Immunology. Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction

Bioassays for Quality Control of Cell & Gene Therapy Products

Antigen Presentation to T lymphocytes

Developing Understanding of CMI. Dr Tom Wilkinson Associate Professor of Respiratory Medicine Faculty of Medicine University of Southampton UK

Designing An)gen- specific Immunotherapy for Treatment of Type 1 Diabetes.

Robert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School

Histocompatibility antigens

Significance of the MHC

Out-of-sequence signal 3 as a mechanism for virusinduced immune suppression of CD8 T cell responses

Targeting the Trimolecular Complex for Immune Intervention. Aaron Michels MD

NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies

Darwinian selection and Newtonian physics wrapped up in systems biology

Dendritic cell subsets and CD4 T cell immunity in Melanoma. Ben Wylie 1 st year PhD Candidate

Synergistic combinations of targeted immunotherapy to combat cancer

Determinants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco

TITLE: Development of Antigen Presenting Cells for adoptive immunotherapy in prostate cancer

Low Avidity CMV + T Cells accumulate in Old Humans

Transcription:

Exploring S. Typhi-Specific HLA-E Restricted Immune Responses in Pediatric and Adult Ty21a Recipients Mark Rudolph PhD Candidate- University of Maryland Graduate Program in Life Sciences Institute for Global Health Center for Vaccine Development

Age (Years) Age (Years) Volunteer Information Pediatric Volunteers Age of Volunteers Tested n =28 n =11 Total n = 39 Pediatric volunteers receive Ty21a vaccine for medically indicated reasons (travel to endemic regions). Recruitment is ongoing. Pediatric (total) n = 15 Adult (total) n = 15 (9 individuals)

Pediatric Immune Responses Cell mediated immune responses (CMI) have been shown to change throughout childhood and into adulthood He et al., J Virol. 80: 11756-66, 2006 Pendergast et al., Nat Rev Immunol. 12: 636-48, 2012 Thresholds of antigen exposure for inducing immunity also shift through increasing age Watson, B., J. Infect Disease. Suppl 2: S143-6, 2008 Our lab has shown that children may have less multifunctional responses than adults in response to stimulation with superantigen Booth et al., Front Immunol. 5: 249, 2014 We don t know how these differences may impact the pediatric response to Ty21a vaccination, or how could this affect Ty21a protection against the development of typhoid disease in different age groups

% Efficacy Ty21a Efficacy in Children - Field Studies Age Group Placebo Vaccine 5-9 yr # of children 7193 7034 # of cases 25 10 Efficacy - 59% (16-80%) 10-14 yr # of children 9710 9992 # of cases 32 11 Efficacy - 67% (35-83%) 15 yr # of children 5001 5142 # of cases 13 2 Efficacy - 85% (42-96%) Ty21a Vaccine Recipients Mean (range) Adapted from: Levine et al., The Lancet 329: 1049-1052, 1987 Ty21a efficacy was previously observed to be lower at a younger age; however, (1) these data showed large overlapping confidence intervals, and (2) responsiveness does not necessarily correlate with efficacy

Target Cells 721.221.AEH Experimental Design Target Cells 721.221.AEH PBMC S. Typhi Infection + γ-irradiation γ-irradiation Infected AEH Co-culture Thanks to Dr. McArthur for this slide 14-18 hr incubation Uninfected AEH Co- Culture (Control) Mass Cytometry (38 parameters) Memory subsets Cytotoxic T cells Helper T cells

HLA-E Restricted Antigen Presentation Non-classical MHC class Ib GroEL-specific T cell Present a more conserved set of peptides: HLA-A2 leader peptide (inhibitory) Bacterial chaperonins (stimulatory) Heat-shock proteins (stimulatory) We have shown in adult volunteers HLA-E restricted CD8 + T cell responses for up to 2 years following Ty21a vaccination HLA-E TCR β 2 m Salerno et al. J. Immunol. 173: 5852-5862, 2004 Salerno et al. Clin Vaccine Immunol 17: 1305-1314, 2010 Adapted from: Rodgers et al. Nat Rev Immunol 5: 459-71, 2005

CD8 Activation (CD69+) HLA-E restricted S. Typhi responses Gated on CD8 + T effector memory (CD62L - /CD45RA - ) Cells 56% % CD69 + 33% 40 % % Responders Baseline Post-Vaccination Response above Baseline Expression of the activation marker CD69 on CD8 + T EM cells provides preliminary data that HLA-E-restricted S. Typhi responses are observed in a higher proportion of adults than children Pediatric (14-15) n = 5 Pediatric (16-17) n = 9 Adult (total) n = 9 Unpaired t-test Median (interquartile range)

% Effector Molecule Baseline HLA-E restricted S. Typhi-responses Gated on CD8 + T effector memory (CD62L - /CD45RA - ) Cells CD107a IFNγ TNFα IL-2 MIP-1β Granzyme B IL-17A Both children and adults exhibited baseline HLA-Erestricted S. Typhi CD8 + effector memory responses Pediatric (14-15) n = 5 Pediatric (16-17) n = 9 Adult (total) n = 9 Unpaired t-test Median (interquartile range)

% Effector Molecule Ty21a vaccination elicits increases in HLA-E restricted S. Typhi responses Gated on CD8 + T effector memory (CD62L - /CD45RA - ) Cells * CD107a IFNγ TNFα IL-2 MIP-1β Granzyme B No differences in increases above baseline HLA-Erestricted S. Typhi-responsive CD8 + T em effectors were observed between children and adults IL-17A Pediatric (14-15) n = 5 Pediatric (16-17) n = 9 Adult (total) n = 9 Unpaired t-test Median (interquartile range) * p = 0.05

% Effector Molecule Ty21a vaccination elicits increases in HLA-E restricted multifunctional S. Typhi-responses Gated on CD8 + T effector memory (CD62L - /CD45RA - ) Cells ** * TNFα + + + + IFNγ - + - + IL-2 - - + + * Pediatric (14-15) n = 5 Pediatric (16-17) n = 9 Adult (total) n = 9 Unpaired t-test Median (interquartile range) * p = 0.05 ** p = 0.01 Preliminary analyses showed some differences in increases above baseline HLA-Erestricted S. Typhi-responsive MF CD8 + T em effectors between children and adults

Conclusions Expression of the activation marker CD69 on CD8+ T EM cells provides preliminary data that HLA-E-restricted S. Typhi responses are observed in a higher proportion of adults than children Children exhibited baseline HLA-E-restricted CD8 + effector memory responses to S. Typhi antigens, suggesting previous exposure to HLA-Erestricted antigens It appears that for some functions the proportion of responders following vaccination in adults are higher than in children (analyses ongoing) Preliminary analyses showed some differences in increases above baseline HLA-E-restricted S. Typhi-responsive MF CD8+ T EM effectors between children and adults. These differences, however, appear to be less than those observed following SEB stimulation.

Future Directions Expand our HLA-E restriction experiments to include our youngest volunteers (6-14 years, n=8) Continue our analysis of soluble antigen (GroEL, OmpC, FliC) responses in pediatric and adult helper T cells Use Epstein-Barr Virus transformed autologous B-lymphoblastoid cell lines (already generated) to measure responses to classical HLA-restricted (HLA-A,B,C) S. Typhi antigen presentation in pediatric and adult T cells Assess Ty21a vaccination induced correlations between S. Typhi immune responsiveness and functional characteristics of the gut microbiota (in cooperation with the Institute for Genome Sciences)

Acknowledgements Center Vaccine Development, UMB Immunology Group Marcelo B. Sztein Monica McArthur Stephanie Fresnay Rosangela Mezghanni Franklin Toapanta Jay Booth Rekha Rapaka Rezwan Wahid Paula Bernal Cathy Storrer Regina Harley Haiyan Chen Thesis Committee Marcelo Sztein (advisor) Monica McArthur Larry Magder Claire Fraser Eileen Barry George Lewis CVD Supported by grants U19 AI082655 (UM-CCHI) & R01 AI-36525 from the NIH